Directed new share issue in Bavarian Nordic Research Institute A/S (DK) — DKK 80 million

Carnegie acted as lead manager in the directed new share issue in Bavarian Nordic Research Institute A/S, a Danish biotechnology company involved in research and development of platform technologies for the production of therapeutic vaccines and gene therapy.June, 2001.